| [1] |
Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5):277-300.
|
| [2] |
Pan LL, Cheng JY, Zhou M, et al. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-Ag) function as prognostic biomarkers in patients with primary cervical cancer[J]. J Cancer Res Clin Oncol, 2012, 138:239-246.
|
| [3] |
Jemal A, Bray F, Center MM, et al. Global cancer statistics, 2011[J]. CA Cancer J Clin, 2011, 61:69-90.
|
| [4] |
Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of cervix. Blaustein's pathology of female genital tract[M].NY: Springer-Verlag, 2002, 325-381.
|
| [5] |
Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma[J]. Cancer, 1977, 40:1621-1628.
|
| [6] |
Suminami Y, Nagashima S, Vujanovic NL, et al. Inhibition of apoptosis in human tumor cells by the tumor-associated serpin, SCC antigen-1[J]. Br J Cancer, 2000, 82:981-989.
|
| [7] |
Murakami A, Suminami Y, Hirakawa H, et al. Squamous cell carcinoma antigen suppresses radiation-induced cell death[J]. Br J Cancer, 2001, 84:851-858.
|
| [8] |
Gadducci A, Tana R. The serum assay of tumor markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer[J]. Crit Rev Oncol Hemantol, 2008, 66(1):10-20.
|
| [9] |
Yu XF, Zhang Y, Yao ZB, et al. Serum tumor markers in patients with chronic kidney disease[J]. Scand J Clin Lab Invest, 2007, 67:661-667.
|
| [10] |
Ogino I, Nakayama H, Okamoto N, et al. the role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy[J]. Int J Gynecol Cancer, 2006, 16(3):1094-1100.
|
| [11] |
Takeda M, Sakuragi N, Okamoto K, et al. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix[J]. Acta Obstet Gynecol Scand, 2002, 81(5):451-457.
|
| [12] |
Gadducci A, Tana R, Cosio S, et al. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literature[J]. Crit Rev Oncol Hematol, 2008, 66:10-20.
|
| [13] |
Jeong BK, Choi DH, Huh SJ, et al.The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix[J]. Radiat Oncol J, 2011, 29:191-198.
|
| [14] |
Lin H, ChangChien CC, Huang EY, et al. The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer[J]. Acta Obstet Gynecol Scand, 2000, 79(2):140-144.
|
| [15] |
Yoon SM, Shin KH, Kim JY, et al. Use of serum squamous cell carcinoma antigen for follow-up monitoring of cervical cancer patients who were treated by concurrent chemoradiotherapy[J]. Radiat Oncol, 2010, 5:78.
|
| [16] |
Ngan HY, Chan SY, Wong LC, et al. Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix[J]. Gynecol Oncol, 1990, 37:260-263.
|
| [17] |
Yin MZ, Hou Y, Zhang T, et al. Evaluation of chemotherapy response with serum squamous cell carcinoma antigen level in cervical cancer patients: A prospective cohort study[J]. PLoS One, 2013, 8:e54969.
|
| [18] |
Yuan SH, Liang XF, Jia WH, et al. Molecular diagnosis of sentinel lymph node metastases in cervical cancer using squamous cell carcinoma antigen[J]. Clin Cancer Res, 2008, 14(17):5571-5578.
|
| [19] |
Hsu KF, Huang SC, Shiau AL, et al. Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer[J]. Int J Gynecol Cancer, 2007, 17(1):174-181.
|